Adial Pharmaceuticals, Inc. (ADIL) Earnings
|
Expand Research on ADIL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -14.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/14/25 | Q325 | -$0.08 | $0.00 | -$0.08 | N/A | N/A | N/A |  | | Details | |
8/13/25  |
Q225 | N/A | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/15/23 | Q223 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/15/23 | Q123 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/1/23 | Q422 | N/A | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/16/22 | Q322 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/15/22 | Q222 | -$0.25 | -$0.16 | -$0.09 | N/A | N/A | N/A | | | Details |
